Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, tolerability, and pharmacokinetics data for ASM-024 in healthy subjects and individuals with moderate asthma, across …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ASM-024

Snippet

Sponsor: Asmacure Ltée | Conditions: Asthma | Phase 1, Phase 2 | Status: TERMINATED